248 related articles for article (PubMed ID: 21129341)
1. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.
Davey RJ; Jones TW; Fournier PA
J Diabetes Sci Technol; 2010 Nov; 4(6):1457-64. PubMed ID: 21129341
[TBL] [Abstract][Full Text] [Related]
2. The effect of short-term use of the Guardian RT continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus.
Davey RJ; Stevens K; Jones TW; Fournier PA
Prim Care Diabetes; 2012 Apr; 6(1):35-9. PubMed ID: 22047939
[TBL] [Abstract][Full Text] [Related]
3. Analysis: high-tech diabetes technology and the myth of clinical "plug and play".
Weinzimer SA
J Diabetes Sci Technol; 2010 Nov; 4(6):1465-7. PubMed ID: 21129342
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemia alarm enhancement using data fusion.
Skladnev VN; Tarnavskii S; McGregor T; Ghevondian N; Gourlay S; Jones TW
J Diabetes Sci Technol; 2010 Jan; 4(1):34-40. PubMed ID: 20167165
[TBL] [Abstract][Full Text] [Related]
5. Detection of hypoglycemia associated EEG changes during sleep in type 1 diabetes mellitus.
Snogdal LS; Folkestad L; Elsborg R; Remvig LS; Beck-Nielsen H; Thorsteinsson B; Jennum P; Gjerstad M; Juhl CB
Diabetes Res Clin Pract; 2012 Oct; 98(1):91-7. PubMed ID: 22809714
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network.
Diabetes Research in Children Network (DirecNet) Study Group
Diabetes Care; 2004 Mar; 27(3):722-6. PubMed ID: 14988292
[TBL] [Abstract][Full Text] [Related]
7. Clinically relevant hypoglycemia prediction metrics for event mitigation.
Harvey RA; Dassau E; Zisser HC; Bevier W; Seborg DE; Jovanovič L; Doyle FJ
Diabetes Technol Ther; 2012 Aug; 14(8):719-27. PubMed ID: 22690875
[TBL] [Abstract][Full Text] [Related]
8. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
Oriot P; Hermans MP
J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333
[TBL] [Abstract][Full Text] [Related]
9. Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.
Deiss D; Kordonouri O; Hartmann R; Hopfenmüller W; Lüpke K; Danne T
Pediatr Diabetes; 2007 Jun; 8(3):157-62. PubMed ID: 17550426
[TBL] [Abstract][Full Text] [Related]
10. GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children.
Tsalikian E; Kollman C; Mauras N; Weinzimer S; Buckingham B; Xing D; Beck R; Ruedy K; Tamborlane W; Fiallo-Scharer R;
Diabetes Technol Ther; 2004 Oct; 6(5):559-66. PubMed ID: 15628809
[TBL] [Abstract][Full Text] [Related]
11. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
Danne T; Tsioli C; Kordonouri O; Blaesig S; Remus K; Roy A; Keenan B; Lee SW; Kaufman FR
Diabetes Technol Ther; 2014 Jun; 16(6):338-47. PubMed ID: 24447074
[TBL] [Abstract][Full Text] [Related]
12. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
13. An integrated multivariable artificial pancreas control system.
Turksoy K; Quinn LT; Littlejohn E; Cinar A
J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Home Study on Nocturnal Hypoglycemic Alarms Using a New Fully Implantable Continuous Glucose Monitoring System in Type 1 Diabetes.
Wang X; Ioacara S; DeHennis A
Diabetes Technol Ther; 2015 Nov; 17(11):780-6. PubMed ID: 26177299
[TBL] [Abstract][Full Text] [Related]
15. Relationships among different glycemic variability indices obtained by continuous glucose monitoring.
Saisho Y; Tanaka C; Tanaka K; Roberts R; Abe T; Tanaka M; Meguro S; Irie J; Kawai T; Itoh H
Prim Care Diabetes; 2015 Aug; 9(4):290-6. PubMed ID: 25456706
[TBL] [Abstract][Full Text] [Related]
16. A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
Guelho D; Paiva I; Batista C; Barros L; Carrilho F
Minerva Endocrinol; 2014 Jun; 39(2):127-33. PubMed ID: 24736487
[TBL] [Abstract][Full Text] [Related]
17. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk.
Schiaffini R; Ciampalini P; Fierabracci A; Spera S; Borrelli P; Bottazzo GF; Crinò A
Diabetes Metab Res Rev; 2002; 18(4):324-9. PubMed ID: 12203948
[TBL] [Abstract][Full Text] [Related]
18. The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.
Fabris C; Nass RM; Pinnata J; Carr KA; Koravi CLK; Barnett CL; Oliveri MC; Anderson SM; Chernavvsky DR; Breton MD
Diabetes Care; 2020 Apr; 43(4):799-805. PubMed ID: 32144167
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia detection in critical care using continuous glucose monitors: an in silico proof of concept analysis.
Pretty CG; Chase JG; Le Compte A; Shaw GM; Signal M
J Diabetes Sci Technol; 2010 Jan; 4(1):15-24. PubMed ID: 20167163
[TBL] [Abstract][Full Text] [Related]
20. What is hypoglycemia in patients with well-controlled type 1 diabetes treated by subcutaneous insulin pump with use of the continuous glucose monitoring system?
Larsen J; Ford T; Lyden E; Colling C; Mack-Shipman L; Lane J
Endocr Pract; 2004; 10(4):324-9. PubMed ID: 15760775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
